Clinical Trial Update: A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD) [Phase 2]

View source ↗

Summary

BRII-296 was studied in adults with severe postpartum depression in a Phase 2 trial that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Depression

Drugs mentioned

• BRII-296

Snippet

Sponsor: Brii Biosciences Limited | Conditions: Severe Postpartum Depression | Phase 2 | Status: COMPLETED